Can You Take Celexa While Pregnant? What to Know

Table of Contents

Overview
Quick Answer: Can You Take Celexa While Pregnant?
Why Mental Health Treatment Matters During Pregnancy
What Research Says About Celexa in Pregnancy
Possible Risks and Newborn Effects to Know
Celexa Dose, Timing, and Monitoring in Pregnancy
Should You Stop or Taper Celexa During Pregnancy?
Switching Antidepressants During Pregnancy
Celexa and Breastfeeding
How to Talk to Your OB and Prescriber
Pregnancy, Celexa, and Mental Health Support
Key Takeaways
Frequently Asked Questions

Overview

If you are pregnant and taking Celexa (citalopram), you may feel pulled in two directions at once. You want to protect the pregnancy, and you also want to protect your mental health, especially if Celexa has helped you function, sleep, eat, or feel emotionally steady. The most evidence-based approach is not “always stop” or “always continue,” but a shared decision with your OB and prescriber that weighs your symptom history, relapse risk, and the safety data we have.

This topic can be stressful because online answers often sound absolute. In reality, clinicians typically focus on two practical questions: how stable you are on your current plan, and what the lowest-risk path is to keep you stable through pregnancy and postpartum. The American College of Obstetricians and Gynecologists' (ACOG) perinatal mental health guidance supports individualized treatment, including the thoughtful use of medications when clinically indicated.

Quick Answer: Can You Take Celexa While Pregnant?

For many people, citalopram use in pregnancy is considered when the benefits of staying well outweigh potential risks. Available epidemiologic data have not established an increased risk of major birth defects or miscarriage with citalopram, but SSRIs, including Celexa, are associated with potential newborn complications when used late in pregnancy, such as poor neonatal adaptation symptoms and a small increased risk of persistent pulmonary hypertension of the newborn (PPHN).

One of the most important safety points is not to stop Celexa suddenly. Discontinuing antidepressants can increase relapse risk, and abrupt stopping can also cause discontinuation symptoms that may worsen sleep, anxiety, and functioning.

Why Mental Health Treatment Matters During Pregnancy

Treating depression and anxiety during pregnancy is not just about comfort. Symptoms can affect sleep, nutrition, substance use, prenatal appointment follow-through, relationship stability, and safety. If you have a history of severe symptoms, prior hospitalization, panic that disrupts eating or sleep, or postpartum mood episodes, stability may be a medical priority, not a nice to have.

Clinicians also weigh the risk of relapse if medication is stopped. The Celexa label notes evidence that women who discontinue antidepressants during pregnancy may be more likely to relapse than women who continue, which is why the risks of untreated depression are part of the decision-making process.

What Research Says About Celexa in Pregnancy

Overall Safety Data

Large observational studies and postmarketing data have limitations, but they are the main human evidence base we have. The FDA label for Celexa states that available epidemiologic data and postmarketing reports with citalopram have not established an increased risk of major birth defects or miscarriage.

Some studies suggest associations with outcomes like preterm delivery or low birth weight, but it is difficult to separate medication effects from the effects of underlying depression, anxiety, or other factors.

First Trimester Exposure

First-trimester decisions tend to focus on major malformations, because that is the main organ formation window. For citalopram, the overall data have not shown a clear, consistent signal of major birth defect risk in the way some older headlines suggest, but your clinician may still review personal factors like diabetes, smoking, other meds, and family history that can influence baseline risk.

Second and Third Trimester Exposure

Later pregnancy discussions often shift from malformations to delivery and newborn transition. With SSRIs (including Celexa), clinicians commonly discuss the possibility of poor neonatal adaptation symptoms and the small increased risk of PPHN with late-pregnancy exposure. This is also where dose, symptom control, and a plan for postpartum monitoring become especially important.

Possible Risks and Newborn Effects to Know

It helps to separate possible risk signals from what most families actually see. Many people take SSRIs in pregnancy without serious complications, but clinicians still counsel on what to watch for.

• Poor Neonatal Adaptation Symptoms: Infants exposed to SSRIs late in the third trimester may have temporary symptoms after birth such as respiratory distress, temperature instability, feeding difficulties, jitteriness, irritability, or constant crying. These symptoms are often mild and typically resolve within days to about two weeks with supportive care.

• Persistent Pulmonary Hypertension of the Newborn: The Celexa label states that late-pregnancy SSRI exposure may be associated with an increased risk of PPHN. The label also notes that PPHN occurs in about 1 to 2 per 1,000 live births in the general population.

• Preterm Birth and Low Birth Weight (Mixed Evidence): Some studies show associations between SSRI exposure and preterm delivery or low birth weight, but depression itself is also associated with pregnancy complications, making causality difficult to untangle.

If your care team knows you are taking citalopram during pregnancy, they can plan newborn observation appropriately and reduce last-minute stress.

Celexa Dose, Timing, and Monitoring in Pregnancy

Pregnancy changes metabolism, sleep, and stress physiology, which can change how medication feels. Some people feel stable without changes, while others notice symptom return and need closer follow-up. Rather than assuming you must lower the dose, many clinicians focus on the lowest effective dose that keeps symptoms controlled, because relapse can be risky too.

If your OB or prescriber raises safety-specific concerns, they may review your full medical history, other medications, and any cardiac risk factors. For Celexa specifically, clinicians may be mindful of dose-related QT considerations in some patients, which is part of why dosing decisions are individualized.

Should You Stop or Taper Celexa During Pregnancy?

Many people’s first instinct is to stop as soon as they see a positive test. In practice, clinicians usually discourage abrupt stopping because it can cause discontinuation symptoms (including insomnia, irritability, dizziness, and anxiety) and can increase relapse risk.

A taper may be discussed when symptoms have been stable for a long time, relapse risk is low, and you have strong non-medication supports in place. Even then, the conversation typically includes a plan for what you will do if symptoms return, because pregnancy and postpartum are high-risk periods for recurrence.

Switching Antidepressants During Pregnancy

Switching medications during pregnancy is not automatically safer. A switch can introduce instability, withdrawal symptoms, and a trial-and-error period that may be harder during pregnancy when sleep and nausea are already factors.

A switch is more commonly considered if Celexa is not working, side effects are severe, or there is a specific safety concern in your clinical situation. If a switch is being considered, it is usually planned carefully to maintain symptom control and to avoid abrupt SSRI discontinuation.

Celexa and Breastfeeding

Many people ask whether they must stop citalopram to breastfeed. If citalopram is required by the mother, it is not a reason to discontinue breastfeeding.

The Celexa label notes that citalopram is present in human milk and reports that some breastfed infants have experienced irritability, restlessness, excessive sleepiness, decreased feeding, or weight loss. Clinicians typically advise monitoring the infant for these signs and coordinating with the pediatrician.

How to Talk to Your OB and Prescriber

Going into the conversation with clear questions can reduce anxiety and speed up a plan.

• What Is My Relapse Risk If I Stop?: Ask based on your history, not averages, including prior episodes and postpartum history.

• What Are the Biggest Pregnancy-Specific Risks in My Case?: This is where your OB can factor in medical history and other medications.

• What Should We Monitor Each Trimester?: Many plans include symptom check-ins, sleep tracking, and postpartum prevention planning.

• What Should the Newborn Team Know?: If you continue late in pregnancy, ask what the hospital typically monitors after delivery.

• Should I Join a Pregnancy Exposure Registry?: The Celexa label notes a pregnancy exposure registry for antidepressants and encourages enrollment.

ACOG emphasizes perinatal mental health screening and treatment planning across pregnancy and postpartum, so it is appropriate to ask for coordinated care rather than managing this alone.

Pregnancy, Celexa, and Mental Health Support

Pregnancy can intensify rumination, health anxiety, relationship stress, and sleep disruption, even when medication is helping. Therapy can support you in building coping skills, reducing reassurance-seeking loops, and creating a practical plan for triggers that are likely to show up during pregnancy and postpartum. It can also help you evaluate decisions from a steadier place, rather than from panic or guilt. If access is a barrier, 7 Cups offers access to a licensed therapist through online therapy, which can make it easier to get consistent support while you coordinate care with your OB and prescriber.

Key Takeaways

Celexa (citalopram) may be continued during pregnancy for many people when the benefits of symptom stability outweigh potential risks. Available data have not established an increased risk of major birth defects or miscarriage, but late-pregnancy SSRI exposure is associated with possible newborn adaptation symptoms and a small increased risk of PPHN, so planning and monitoring matter. Do not stop Celexa abruptly, because discontinuation symptoms and relapse can be significant, and pregnancy/postpartum are periods when mental health support often needs to be stronger, not weaker. The best decision is individualized and ideally made with both your OB and prescriber involved.

For more support, join our empathetic community, chat with a free, trained listener, make progress through a community-driven growth path, or start affordable online therapy today.

Frequently Asked Questions

Read more below for answers to questions commonly asked about this topic.

Is Celexa safe during pregnancy?
No medication is completely risk-free, but Celexa (citalopram) is commonly used during pregnancy when the benefits outweigh potential risks. Available data have not established an increased risk of major birth defects or miscarriage, though individual factors still matter.

Can you take Celexa while pregnant in the first trimester?
Many people continue Celexa during the first trimester, especially if stopping would raise relapse risk. Current evidence has not shown a consistent increase in major birth defects linked to first-trimester citalopram exposure.

Should I stop Celexa if I find out I’m pregnant?
You should not stop Celexa suddenly without medical guidance. Abrupt SSRI discontinuation can cause withdrawal symptoms and significantly increase the risk of depression or anxiety relapse.

Can Celexa cause birth defects?
All pregnancies carry a baseline risk of birth defects, regardless of medication use. Large studies have not established an increased risk of major birth defects specifically associated with citalopram.

What is SSRI neonatal adaptation syndrome with Celexa?
This refers to temporary newborn symptoms after late-pregnancy SSRI exposure, such as jitteriness, feeding difficulty, or respiratory distress. Symptoms are usually mild and resolve within days to about two weeks with supportive care.

Does taking Celexa late in pregnancy increase PPHN risk?
Late-pregnancy SSRI exposure, including Celexa, may be associated with a small increased risk of persistent pulmonary hypertension of the newborn (PPHN). PPHN is rare overall, occurring in about 1 to 2 per 1,000 live births.

Will my baby have withdrawal from Celexa?
Some sources use the word withdrawal, but clinicians more often describe these effects as poor neonatal adaptation. If symptoms occur, they are typically short-lived and monitored after birth.

Can I breastfeed while taking Celexa?
Often, yes, if citalopram is clinically needed. Infants are usually monitored for sleepiness, irritability, feeding problems, or poor weight gain.

Is it safer to switch from Celexa to another SSRI during pregnancy?
Not necessarily, because switching can introduce instability and new side effects. Clinicians usually recommend switching only when there is a clear medical reason rather than as a routine safety step.

Is there a pregnancy registry for Celexa exposure?
Yes, the National Pregnancy Registry for Antidepressants tracks outcomes in people exposed during pregnancy. Enrollment helps improve safety data and may be recommended by your clinician.